Published 5 May 2015 QS Top University ranking for 2015 places Lund University as the world's twentieth by subject (Geography & Area Studies). The QS World University Rankings places Lund University as number 20 world wide in Geography & Area Studies. This is an improvement from last year's position of 21. Lund University as a whole also climbs to rank #60, maintaining a firm grip on the "A top 10

https://www.nateko.lu.se/article/ranked-20-among-geography-departments-world-wide - 2025-01-05

Published 6 May 2015 ICOS Carbon Portal is the central data portal for a European-wide Greenhouse Gas monitoring network. It offers access to research data from ICOS scientists all over Europe, and provides facilities and IT resources supporting modelling activities for elaborated data products. Alex Vermeulen, director of the Carbon Portal Hello Alex Vermeulen! What is the Carbon Portal?– The ICO

https://www.nateko.lu.se/article/carbon-portal-access-carbon-research-data - 2025-01-05

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 16 June 2020 Karl Swärd wants to find answers to how an elevated blood pressure damages the vessels. Photo. Agata Garpenlind High blood pressure damages our blood vessels. It also damages our heart, our brain and our kidneys. A high blood pressure increases the risk of suffering a heart attack and stroke. However,

https://www.medicine.lu.se/article/high-blood-pressure-bloody-serious - 2025-01-05

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 16 June 2020 Åsa Petersén works hard at i to find treatment that slows down Huntington's disease. A person who carries the mutant gene will at some point in his or her life develop the deadly Huntington's disease. This brain disease can be inherited from generation to generation and begins insidiously, making it in

https://www.medicine.lu.se/article/huntingtons-disease-fascinating-and-touching-mystery - 2025-01-05

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 16 June 2020 Gunilla Westergren-Thorsson wants to establish methods to identify risk groups at an early stage. Photo Agata Garpenlind. Pulmonary fibrosis is a severe and life shortening chronic condition. Although most people experience mild symptoms of COVID-19, some patients develop serious and life-threatening c

https://www.medicine.lu.se/article/identification-prognostic-markers-development-chronic-lung-fibrosis-covid-19-patients - 2025-01-05

By ">Sara Liedholm - published 22 June 2020 Paul Franks (Photo: Kennet Ruona) A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluated and impleme

https://www.medicine.lu.se/article/roadmap-precision-medicine-diabetes-care - 2025-01-05

Published 24 June 2020 Adriana Sanna defended a thesis on 20 May, Shamik Mitra on 26 May and Rita Cabrita on 10 June. Adriana Sanna defended a thesis on 20 May, Shamik Mitra on 26 May and Rita Cabrita on 10 June. How come there were three at almost the same time?“All three were admitted simultaneously through MELGEN, a European network that has Marie Curie funding. My trio of doctoral students wer

https://www.medicine.lu.se/article/three-doctoral-thesis-defences-1-week - 2025-01-05

By alexander [dot] doyle [at] med [dot] lu [dot] se (Alexander Doyle) - published 25 June 2020 Postdoctoral researcher Agatheeswaran Subramaniam and PhD Student Kristijonas Žemaitis from the Stem Cell Regulators research group. Photo: Alexander Doyle Researchers from Lund Stem Cell Center have identified a novel target for the expansion of human blood stem cells ex vivo and shed light on the mecha

https://www.medicine.lu.se/article/new-insights-ex-vivo-expansion-transplantable-human-blood-stem-cells - 2025-01-05

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 25 June 2020 Dr. Yuriy Pomeshchik (left) and Dr. Laurent Roybon, lead and senior authors of the study. Photo: Agata Garpenlind Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by

https://www.medicine.lu.se/article/new-research-paves-way-developing-therapies-could-slow-down-alzheimers - 2025-01-05

Published 24 July 2020 Alex Evilevitch (Photo: Tove Smeds) Researchers at Lund University in Sweden have discovered a new method to treat human herpes viruses. The new broad-spectrum method targets physical properties in the genome of the virus rather than viral proteins, which have previously been targeted. The treatment consists of new molecules that penetrate the protein shell of the virus and

https://www.medicine.lu.se/article/antiviral-method-against-herpes-paves-way-combatting-incurable-viral-infections - 2025-01-05

Published 28 July 2020 A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published today in the Journal of the American Medical Association (JAMA) and simu

https://www.medicine.lu.se/article/new-blood-test-shows-great-promise-diagnosis-alzheimers-disease - 2025-01-05

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 5 August 2020 Illustration of the pH-responsive mesoporous silica nanoparticles designed to specifically target lung cancer. A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to sp

https://www.medicine.lu.se/article/new-promising-treatment-uses-smart-nanoparticles-target-lung-cancer - 2025-01-05

Published 18 August 2020 Around 20,000 people have been diagnosed with Parkinson's disease in Sweden. Today, there is no imaging method of changes in the brain that are believed to cause the disease. Researchers at Skåne University Hospital and Lund University have received nearly SEK 7 million from the Michael J Fox Foundation to develop an imaging technique that can more accurately detect and tr

https://www.medicine.lu.se/article/millions-michael-j-fox-foundation-improve-diagnosis-parkinsons - 2025-01-05

By Alexander [dot] doyle [at] med [dot] lu [dot] se (Alexander Doyle) - published 16 September 2020 Immunofluorescence image of human neurons derived from stem cells. Image credit: Agnete Kirkeby Prof. Johan Jakobsson and Assoc. Prof. Agnete Kirkeby from Lund Stem Cell Center and University of Copenhagen, along with co-applicants Prof. Roger Barker from Cambridge, UK and Assoc. Prof. Molly Hammell

https://www.medicine.lu.se/article/researchers-investigate-role-transposable-elements-neuroinflammation-and-parkinsons-disease - 2025-01-05

By press [at] med [dot] lu [dot] se (press[at]med[dot]lu[dot]se) - published 18 September 2020 Erik Renström, dean at the Faculty of Medicine. Photo: Kennet Ruona The University Board has today decided to recommend the dean of the Faculty of Medicine, Erik Renström, as the new vice-chancellor of Lund University for the term of office 2021 to 2026. "This is a big step. I am humble and it is with de

https://www.medicine.lu.se/article/erik-renstrom-proposed-new-vice-chancellor - 2025-01-05

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 23 September 2020 Johan Richter and Ilana Moscatelli. Photo: Åsa Hansdotter Johan Richter's research has resulted in the successful development of gene therapy for the hereditary disease malignant infantile osteopetrosis. For the past few years, the research group has established a collaboration with an American biotec

https://www.medicine.lu.se/article/successful-biotech-collaboration-brings-gene-therapy-project-clinic - 2025-01-05

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 23 September 2020 Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have no

https://www.medicine.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2025-01-05

Published 29 September 2020 A large proportion of our elite athletes are suffering psychological distress during the COVID-19 pandemic, with more women than men reporting adverse reactions. This is demonstrated by the study Psychological Distress and Problem Gambling in Elite Athletes during COVID-19 Restrictions: A Web Survey in Top Leagues of Three Sports during the Pandemic, published in the In

https://www.medicine.lu.se/article/many-elite-athletes-feeling-psychological-distress-during-pandemic - 2025-01-05

Published 29 September 2020 Lund University researchers have developed an analytical model that can effectively detect and identify gene mutations in breast tumours. In the study, which is the largest of its kind anywhere in the world, they are now reporting results from 3,200 breast cancer patients. Lao Saal, cancer researcher at Lund University. Photo: Olle Dahlbäck To assist them, they have uti

https://www.medicine.lu.se/article/new-analytical-method-benefits-breast-cancer-patients - 2025-01-05

By asa [dot] hansdatter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 6 October 2020 A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 20 children in Sweden are diagnosed with neuroblastoma

https://www.medicine.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2025-01-05